P1237: PRELIMINARY RESULTS OF A PHASE Ⅱ STUDY OF ZANUBRUTINIB COMBINED WITH IMMUNOCHEMOTHERAPY IN PATIENTS WITH CD79A/CD79B-MUTANT DIFFUSE LARGE B-CELL LYMPHOMA

• Z. Yan,
• S. Yao,
• H. Wang,
• J. Chu,
• S. Zhao,
• J. Ma,
• B. Wei,
• J. Zheng,
• Q. Lin,
• Z. Xu,
• Z. yao,
• Y. liu

Affiliations

Z. Yan

1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University

S. Yao

1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University

H. Wang

1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University

J. Chu

1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University

S. Zhao

1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University

J. Ma

2 Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University

B. Wei

2 Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University

J. Zheng

2 Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University

Q. Lin

3 Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, zhengzhou

Z. Xu

4 Department of Hematology, Xinyang Central Hospital, xinyang, China

Z. yao

1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University

Y. liu

1 Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University